AREC — Arecor Therapeutics Share News
0.000.00%
- £16.42m
- £13.40m
- £5.05m
REG - Arecor Therapeutics - Final results for 2023
AnnouncementREG - Arecor Therapeutics - Notice of Results
AnnouncementREG - Arecor Therapeutics - Arecor and Medtronic Diabetes collaboration
AnnouncementREG - Arecor Therapeutics - Publication of Full Year Financial Results delayed
AnnouncementREG - Arecor Therapeutics - BOARD CHANGE
AnnouncementREG - Arecor Therapeutics - Arecor and TRx Biosciences research collaboration
AnnouncementRCS - Arecor Therapeutics - Arecor and TRx Biosciences research collaboration
AnnouncementREG - Arecor Therapeutics - Arecor announces launch of Ogluo® in Netherlands
AnnouncementREG - Arecor Therapeutics - Year End Trading Update
AnnouncementREG - Arecor Therapeutics - Arecor announces update on INBRX-101
AnnouncementREG - Arecor Therapeutics - Arecor granted key European patent
AnnouncementREG - Arecor Therapeutics - Expansion of specialty hospital collaboration
AnnouncementREG - Arecor Therapeutics - Appointment of SVP for Tetris Pharma Ltd
AnnouncementREG - Arecor Therapeutics - Agreement with global medical products company
AnnouncementREG - Arecor Therapeutics - Arecor Continues Collaboration with Lilly
AnnouncementREG - Arecor Therapeutics - Product with Arestat technology launched in Europe
AnnouncementREG - AIM - AIM Notice - 07/11/2023
AnnouncementREG - Arecor Therapeutics - Inhibrx milestone triggers payment to Arecor
AnnouncementREG - Arecor Therapeutics - Exercise of rollover options & Total Voting Rights
Announcement